Epirubicin

Form: Injection

Strength: 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL

Reference Brands: Ellence®(US); Farmorubicin®(EU)

Category: Oncology Cancer Care

Epirubicin Hydrochloride is a widely used oncology injectable in the US and EU, primarily indicated for breast cancer, gastric cancer, and bladder cancer. It is a potent anthracycline chemotherapy agent that interferes with DNA replication, leading to cancer cell death. Available in concentrations like 2 mg/mL across multiple vial sizes, Epirubicin offers versatility for intravenous and intravesical administration. Approved under several brands, including Farmorubicin®, it is a key component in combination regimens. Pharmaceutical B2B buyers and distributors in the EU and US recognize Epirubicin as a high-demand, regulated oncology product with broad market application.